Related Experiment Video
Updated: Jul 5, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Does the seizure frequency increase in Ramadan?
Yasemin B Gomceli1, Gulnihal Kutlu, Leyla Cavdar
1Ministry of Health Ankara Training and Research Hospital, Department of Neurology, Ankara, Turkey. yasemingomceli@hotmail.com
Abstract:
During Ramadan, the ninth month of the Islamic lunar calendar, adult Muslims are required to refrain from taking any food, beverages, or oral drugs, as well as from sexual intercourse between dawn and sunset. In this study, we aimed at discovering alterations in drug regimens and the seizure frequency of epileptic patients during Ramadan (15 October 2004-13 November 2004). In the 3 months following Ramadan in the year 2004, 114 patients with epilepsy who were fasting during Ramadan were examined at our Epilepsy Department. Of the 114 patients who were included in the study, 38 patients had seizures and one of these patients developed status epilepticus during Ramadan. When the seizure frequency of these patients during Ramadan was compared to that in the last 1 year and last 3 months period just prior to Ramadan, a statistically significant increase was observed (p<0.001). Moreover, there was an important increase in the risk of having seizures in the patients who changed their drug regimens compared with those who did not (p<0.05). In the patients who received monotherapy or polytherapy, no difference in the frequency of seizures during Ramadan was seen (p>0.05). During Ramadan, an increase in the seizure frequency of patients with epilepsy was observed. The most important reason for this situation was the alteration in the pharmacokinetics and pharmacodynamics of drugs, and consequently, in their efficacy. We believe that in the patients who received monotherapy and who did not change their drug regimes, the increase in seizure frequency may have been related to the changes in their daily rhythms, emotional stress, tiredness and their day-long fasting.
Insights
Epileptic patients experienced a significant increase in seizure frequency during Ramadan fasting. Changes in drug regimens and daily rhythms were identified as key contributing factors to this heightened risk.
Area of Science:
- Neurology
- Clinical Pharmacy
- Islamic Studies
Background:
- Ramadan fasting involves abstaining from food, drink, and oral medications from dawn to sunset.
- Epilepsy management requires consistent medication adherence for seizure control.
Purpose of the Study:
- To investigate changes in drug regimens and seizure frequency among epileptic patients observing Ramadan fasts.
- To identify factors influencing seizure occurrence during Ramadan.
Main Methods:
- A cohort of 114 epileptic patients who fasted during Ramadan were studied retrospectively.
- Seizure frequency during Ramadan was compared to pre-Ramadan periods (1 year and 3 months).
- Risk factors, including drug regimen changes, were analyzed.
Main Results:
- A statistically significant increase in seizure frequency was observed during Ramadan (p<0.001).
- Patients who altered their drug regimens showed a higher risk of seizures (p<0.05).
- No significant difference in seizure frequency was found between monotherapy and polytherapy groups (p>0.05).
Conclusions:
- Ramadan fasting is associated with an increased seizure frequency in epileptic patients.
- Alterations in drug pharmacokinetics/pharmacodynamics and daily rhythms likely contribute to reduced drug efficacy and increased seizures.
- Careful medication management and patient counseling are crucial for epileptic individuals observing Ramadan.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction
Seizures ll: Types
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
